Hydrodynamic methods for delivering fluids to kidney tissues and related materials and methods

Patent metadata

Field	Value
Publication number	US-11911487-B2
Application number	US-201314398697-A
Country	US
Kind code	B2
Filing date	May 3, 2013
Priority date	May 3, 2012
Publication date	Feb 27, 2024
Grant date	Feb 27, 2024

Abstract

The present invention provides methods and materials useful delivering liquids, including liquids comprising nucleic acid molecules into cells. In particular, the present invention provides methods for delivering saline solution, exogenous compositions, and isolated vectors to kidney cells, using the renal vein as a guide and under hydrodynamic pressure. The delivery methods and materials herein are useful to research, prognose, ameliorate symptoms of kidney injury, and treat kidney pathologies.

First claim

What is claimed is:

1. A method to treat a mammalian subject having an acute kidney injury, the method comprising:
occluding the renal vein to the kidney having the acute injury;
administering a retrograde hydrodynamic injection of a therapeutically effective amount of a fluid consisting of an isotonic saline solution into the occluded renal vein of the subject at a site between the occlusion and the kidney such that the renal venous pressure is increased during the injection;
waiting, after the retrograde hydrodynamic injection, for a decrease in the renal venous pressure before unoccluding the renal vein;
unoccluding the renal vein; and,
measuring the serum creatinine level from a biological sample from the mammalian subject where the biological sample is obtained from the mammalian subject after the retrograde hydrodynamic injection is administered and where the serum creatinine level of the mammalian subject is reduced to the normal, baseline level after the injection is administered.

2. The method according to claim 1 , where the administration of the retrograde hydrodynamic injection results in increased peritubular capillary pressure which is maintained during the injection.

3. The method according to claim 1 , where the treatment reduces the sluggish microvascular flow in peritubular capillaries.

4. The method according to claim 1 , where the time between occluding and unoccluding the renal vein is about three minutes or less.

5. The method of claim 1 , where the fluid is administered into the occluded renal vein for a length of time from about 1 second to about 60 seconds.

6. The method according to claim 1 , where the fluid is administered 1 day after the acute kidney injury.

7. The method according to claim 1 , where the acute kidney injury is an ischemia/reperfusion kidney injury.

8. A method to treat an acute kidney injury in a kidney, the method comprising:
occluding the renal vein to the kidney having the acute kidney injury;
delivering a plurality of molecules of a fluid to a tubule lumen of the kidney via the renal vein, wherein the delivering of the molecules comprises administering a retrograde hydrodynamic injection of the fluid into the occluded renal vein at a site between the occlusion and the kidney, the retrograde hydrodynamic injection increasing the renal venous pressure during the injection, and waiting, after the retrograde hydrodynamic injection, for a decrease in the renal venous pressure before unoccluding the renal vein; and
unoccluding the renal vein.

9. The method of claim 8 , where the administration of the retrograde hydrodynamic injection results in decreased serum creatine levels.

10. The method of claim 8 , wherein the retrograde hydrodynamic injection is administered for a length of time longer than five seconds and less than 60 seconds.

11. The method of claim 8 , wherein the fluid consists of a saline solution.

12. A method to treat an acute kidney injury in a kidney, the method comprising:
occluding the renal vein to the kidney having the acute kidney injury;
administering a retrograde hydrodynamic injection of a fluid into the occluded renal vein at a site between the occlusion and the kidney, the retrograde hydrodynamic injection increasing the renal venous pressure during the injection;
waiting, after the retrograde hydrodynamic injection, for a decrease in the renal venous pressure before unoccluding the renal vein; and
unoccluding the renal vein.

Assignees

• Univ Indiana Res & Tech Corp
• Us Gov Veterans Affairs
• Univ Indiana Res & Tech Corp

Inventors

• Bacallao Robert
• Atkinson Simon
• Rhodes George
• Corridon Peter

Classifications

• A61K48/0075 Primary

  characterised by an aspect of the delivery route, e.g. oral, subcutaneous · CPC title

• A61K9/0019

  Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00) · CPC title

• A61K38/443

  acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1) · CPC title

• A61K38/45

  Transferases (2) · CPC title

• A61K48/0058

  Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct · CPC title